Gleneagles Hospital Hong Kong’s Peritoneal Malignancy Treatment Centre has introduced new intraperitoneal chemotherapy procedures, including Hyperthermic Intraperitoneal Chemotherapy (HIPEC) and Pressurised Intraperitoneal Aerosol Chemotherapy (PIPAC), to provide more effective treatment to patients with peritoneal cancer.
Dr Kenneth Tsang, Chief Executive Officer of Gleneagles Hospital Hong Kong, said, “In addition to our advanced radiotherapy facilities, we have also launched a centre dedicated to serving patients with peritoneal metastasis. Our experienced multidisciplinary medical team provides patients with comprehensive diagnostic services and personalised treatments.” The Centre is the first of its kind in Hong Kong catering to patients with peritoneal metastasis. Medical studies have found HIPEC to effectively improve the survival rate of patients with ovarian cancer, gastric cancer or colorectal cancer. The innovative PIPAC treatment is also known to relieve symptoms of peritoneal metastasis and reduce the side effects of chemotherapy, which helps improve the patient’s quality of life.
Related Stories
Future of Work: AI Agents in Action Hackathon Highlights AI Solutions for Healthcare and Business Challenges
The Future of Work: AI Agents in Action Hackathon invited colleagues from across the IHH network to explore how AI agents can help solve everyday challenges in healthcare and business operations.
Gleneagles Hong Kong Champions Health and Wellness at Hong Kong Cyclothon
IHH Healthcare's Gleneagles Hospital Hong Kong supported the 2026 Hong Kong Cyclothon as the event's Official Wellness Partner, helping promote active living and community wellbeing while providing medical support for one of the city's largest mass participation sporting events.
Pantai Hospital Kuala Lumpur Completes First Iberis® RDN Transradial Procedure Across Pantai Hospitals Group
Pantai Hospital Kuala Lumpur has achieved a cardiovascular care milestone with the successful completion of the first Iberis® renal denervation (RDN) transradial procedure within the Pantai hospital network.
Fortis Expands Advanced Respiratory Care with Dedicated Lung Failure Clinics
Fortis Healthcare, part of IHH Healthcare, is strengthening respiratory and transplant care in Delhi through new multidisciplinary Lung Failure Clinics.
Acibadem Advances Cancer Care with Türkiye’s First Private Proton Therapy Programme
Acibadem Healthcare Group, part of IHH Healthcare, is introducing cutting-edge proton therapy in Istanbul to deliver more precise, patient-centred cancer treatment and strengthen regional oncology expertise.
IHH Healthcare Wins Four Awards for Leadership and Learning Excellence
IHH Healthcare has been recognised at the 2026 HCM Excellence Awards® by Brandon Hall Group™ for four innovative programmes in leadership and learning. The awards showcase our commitment to strengthening capability, fostering collaboration and advancing a culture of safety and integrity across its global network.
